12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

• Scopus BioPharma (NASDAQ:SCPS) stock rose 50.0% to $0.12 during Monday's regular session. The current volume of 120.0K shares is 12.4% of Scopus BioPharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.5 million.
• NantHealth (NASDAQ:NH) shares increased by 28.55% to $3.6. The current volume of 183.6K shares is 205.1% of NantHealth's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $27.7 million.
• OncoCyte (NASDAQ:OCX) shares moved upwards by 27.29% to $0.38. The current volume of 1.0 million shares is 282.2% of OncoCyte's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $44.4 million.
• Aptinyx (NASDAQ:APTX) stock increased by 22.1% to $0.33. Trading volume for Aptinyx's stock is 708.6K as of 12:30 EST. This is 297.1% of its average full-day volume over the last 100 days. The company's market cap stands at $22.5 million.
• Concord Medical Services (NYSE:CCM) stock increased by 22.05% to $1.66. The market value of their outstanding shares is at $72.0 million.
• DBV Technologies (NASDAQ:DBVT) stock increased by 22.03% to $1.44. Trading volume for DBV Technologies's stock is 6.6 million as of 12:30 EST. This is 9397.6% of its average full-day volume over the last 100 days. The company's market cap stands at $270.6 million.

Losers

• Applied Molecular (NASDAQ:AMTI) stock fell 58.3% to $0.43 during Monday's regular session. Trading volume for this security as of 12:30 EST is 4.2 million, which is 2651.9% of its average full-day volume over the last 100 days. The company's market cap stands at $16.7 million.
• NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares decreased by 35.43% to $0.83. The current volume of 10.2 million shares is 327.6% of NeuroBo Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $5.4 million.
• HTG Molecular Diagnostics (NASDAQ:HTGM) stock fell 26.36% to $3.13. Trading volume for this security as of 12:30 EST is 524.8K, which is 118.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
• 180 Life Sciences (NASDAQ:ATNF) shares decreased by 21.69% to $1.24. As of 12:30 EST, this security is trading at a volume of 1.3 million shares, making up 235.3% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 million.
• Citius Pharmaceuticals (NASDAQ:CTXR) shares fell 18.01% to $0.84. The current volume of 2.0 million shares is 446.4% of Citius Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $122.2 million. As per the news, the Q4 earnings report came out 2 days ago.
• Puma Biotechnology (NASDAQ:PBYI) stock decreased by 17.6% to $4.11. The current volume of 581.4K shares is 184.9% of Puma Biotechnology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $190.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.